Summit Tx Capital, L.P. Biocryst Pharmaceuticals Inc Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 189,086 shares of BCRX stock, worth $1.93 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
189,086Holding current value
$1.93 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
291Shares Held
175MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$221 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$204 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$91.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$88.8 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$79.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.9B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...